Silverback Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 16.7

EPO Patents = 1

Trademarks = 1

Forward Citations = 24

Loading Chart...

8 inventors (with patents filed for the assignee):

Peter Robert Baum (6 out of 31 patents)

Sean Wesley Smith (5 out of 5 patents)

Craig Alan Coburn (4 out of 58 patents)

4. Philip Tan (2 out of 10 patents)

5. Brenda L Stevens (2 out of 18 patents)

6. Robert Dubose (2 out of 3 patents)

7. Valerie Odegard (2 out of 4 patents)

8. Peter A Thompson (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 11541126 - Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereof (2023-01-03),

2. 11179473 - Nectin-4 antibody conjugates and uses thereof (2021-11-23),

3. 10519131 - Benzazepine compounds, conjugates, and uses thereof (2019-12-31),

4. 10442790 - Benzazepine compounds, conjugates, and uses thereof (2019-10-15),

5. 10428045 - Benzazepine compounds, conjugates, and uses thereof (2019-10-01),

6. 10239862 - Benzazepine compounds, conjugates, and uses thereof (2019-03-26),

Company Overview

Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology therapies. Their lead product candidate is designed to activate an immune response to selectively target cancer cells. Their innovative approach holds promise for improving outcomes for cancer patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

6 Patents

#316 in Seattle, WA

#1,073 in Washington

#45,102 in US

Seattle, WA, United States of America

Silverback Therapeutics, Inc.

Forward Citations = 24

8 inventors:

Peter Robert Baum (6 out of 31 patents)

Sean Wesley Smith (5 out of 5 patents)

Craig Alan Coburn (4 out of 58 patents)

4. Philip Tan (2 out of 10 patents)

5. Brenda L Stevens (2 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Silverback Therapeutics, Inc.. Retrieved from https://idiyas.com/company/silverback-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]